Organigram Global (OGI) Non-Current Assets (2018 - 2025)

Organigram Global (OGI) posted quarterly Non-Current Assets of $201.5 million for Q3 2025, up 88.74% year-on-year from $106.8 million in Q3 2024, and up 88.74% on a QoQ basis from $106.8 million in Q3 2024.

Organigram Global (OGI) Non-Current Assets (2018 - 2025) Analysis & Trends

Organigram Global (OGI) has reported Non-Current Assets for 8 consecutive years, with $201.5 million the latest figure, recorded in Q3 2025.

  • Quarterly Non-Current Assets rose 88.74% year-over-year to $201.5 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $690.6 million (down 4.76% YoY) and the FY2025 annual result came in at $201.5 million, up 88.74% from the prior year.
  • Non-Current Assets climbed to $201.5 million in Q3 2025 per OGI's latest filing, from $106.8 million in the prior quarter.
  • Over the last five years, Non-Current Assets for OGI reached as high as $276.0 million in Q3 2022 and fell as low as $106.3 million in Q3 2023.
  • A 5-year average of $197.9 million and a median of $218.8 million in 2021 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2021 — Non-Current Assets decreased 11.37% — and 2025, when it surged 88.74%.
  • Year by year, Non-Current Assets stood at $236.0 million in 2021, then rose by 16.95% to $276.0 million in 2022, then slumped by 61.5% to $106.3 million in 2023, then advanced by 0.45% to $106.8 million in 2024, then jumped by 88.74% to $201.5 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $201.5 million, $106.8 million, and $106.3 million for Q3 2025, Q3 2024, and Q3 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Organigram Global 89.89 Mn 122.96 Mn 28.97 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 201.51 Mn
Sep 30, 2024 106.76 Mn
Sep 30, 2023 106.28 Mn
Aug 31, 2022 276.04 Mn
Aug 31, 2021 236.03 Mn
Feb 28, 2021 260.51 Mn
Nov 30, 2020 265.00 Mn
Aug 31, 2020 197.15 Mn
May 31, 2020 193.82 Mn
Feb 29, 2020 293.94 Mn
Aug 31, 2019 175.67 Mn
May 31, 2019 195.52 Mn
Aug 31, 2018 75.88 Mn